Joint disease caused by defective gp130-mediated STAT signaling.
about
Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularizationTargeting of the innate immunity/inflammation as complementary anti-tumor therapies.Tocilizumab in pediatric rheumatology: the clinical experience.IL-6 blockers in systemic onset juvenile idiopathic arthritis.Old and new therapeutics for Rheumatoid Arthritis: in vivo models and drug development.Association of OSMR gene polymorphisms with rheumatoid arthritis and systemic lupus erythematosus patients.
P2860
Joint disease caused by defective gp130-mediated STAT signaling.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Joint disease caused by defective gp130-mediated STAT signaling
@nl
Joint disease caused by defective gp130-mediated STAT signaling.
@ast
Joint disease caused by defective gp130-mediated STAT signaling.
@en
type
label
Joint disease caused by defective gp130-mediated STAT signaling
@nl
Joint disease caused by defective gp130-mediated STAT signaling.
@ast
Joint disease caused by defective gp130-mediated STAT signaling.
@en
prefLabel
Joint disease caused by defective gp130-mediated STAT signaling
@nl
Joint disease caused by defective gp130-mediated STAT signaling.
@ast
Joint disease caused by defective gp130-mediated STAT signaling.
@en
P2860
P921
P356
P1433
P1476
Joint disease caused by defective gp130-mediated STAT signaling
@en
P2093
Tadamitsu Kishimoto
P2860
P2888
P304
P356
10.1186/AR400
P407
P50
P577
2002-01-22T00:00:00Z
P5875
P6179
1049512253